financetom
Business
financetom
/
Business
/
Aurion Resources Considering Options Regarding Notice From B2Gold
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aurion Resources Considering Options Regarding Notice From B2Gold
May 6, 2024 6:33 AM

08:56 AM EDT, 05/06/2024 (MT Newswires) -- Aurion Resources ( AIRRF ) , which rose 3% on Friday, said Monday that it is considering several options regarding a notice of sale and offer from B2Gold ( BTG ) .

In the notice, B2Gold ( BTG ) said it has held talks with several parties to determine its response to the notice of sale and offer. The company is also considering other strategic alternatives, at both the asset and corporate level. Aurion said the talks could continue beyond the current expiry date of the notice of May 9, whether or not Aurion accepts the offer.

In March, B2Gold ( BTG ) said it had received an offer from Rupert Resources ( RUPRF ) to buy B2Gold's ( BTG ) 70% interest in its joint venture with Aurion. Under the offer, Rupert would pay with about 28.6 million newly issued shares, valuing B2Gold's ( BTG ) stake in the joint venture at $102.8 million.

Aurion has a right of first refusal should B2Gold ( BTG ) sell its interest in the joint venture, which owns properties located in the Central Lapland Greenstone Belt in northern Finland.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vericel Gets US FDA Approval of NexoBrid to Treat Children With Severe Thermal Burns
Vericel Gets US FDA Approval of NexoBrid to Treat Children With Severe Thermal Burns
Aug 15, 2024
04:52 PM EDT, 08/15/2024 (MT Newswires) -- Vericel ( VCEL ) said Thursday the US Food and Drug Administration has approved NexoBrid for eschar removal in pediatric patients with deep partial-thickness and/or full-thickness thermal burns. The company said it's expanding its target client base to include the about 20 pediatric burn centers in the US. Price: 47.05, Change: +0.91, Percent...
Fair Isaac Insider Sold Shares Worth $2,585,510, According to a Recent SEC Filing
Fair Isaac Insider Sold Shares Worth $2,585,510, According to a Recent SEC Filing
Aug 15, 2024
04:53 PM EDT, 08/15/2024 (MT Newswires) -- Marc F McMorris, Director, on August 13, 2024, sold 1,478 shares in Fair Isaac ( FICO ) for $2,585,510. Following the Form 4 filing with the SEC, McMorris has control over a total of 242 shares of the company, with 242 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/814547/000121465924014822/xslF345X03/marketforms-66779.xml Price: 1,735.38, Change: +1.59, Percent Change:...
Amphenol Insider Sold Shares Worth $16,251,825, According to a Recent SEC Filing
Amphenol Insider Sold Shares Worth $16,251,825, According to a Recent SEC Filing
Aug 15, 2024
04:52 PM EDT, 08/15/2024 (MT Newswires) -- Craig A Lampo, Senior Vice President & CFO, on August 14, 2024, sold 250,000 shares in Amphenol ( APH ) for $16,251,825. Following the Form 4 filing with the SEC, Lampo has control over a total of 358,000 shares of the company, with 218,116 shares held directly and 139,884 controlled indirectly. SEC Filing:...
Revolution Medicines Insider Sold Shares Worth $716,389, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $716,389, According to a Recent SEC Filing
Aug 15, 2024
04:53 PM EDT, 08/15/2024 (MT Newswires) -- Stephen Michael Kelsey, President, Research and Development, on August 13, 2024, sold 16,667 shares in Revolution Medicines ( RVMD ) for $716,389. Following the Form 4 filing with the SEC, Kelsey has control over a total of 269,073 shares of the company, with 269,073 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1628171/000161071724000427/xslF345X03/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved